The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Cohen-Dayag Anat | Director | Grant(A) | 100K | — | $0 |
| Jul 29, 2026 | Perry Eran | Director | Grant(A) | 8K | — | $0 |
| Jul 29, 2026 | Perry Eran | Director | Grant(A) | 10K | — | $0 |
| Jul 29, 2026 | Ferre Pierre | Chief Operating Officer | Grant(A) | 70K | — | $0 |
| Jul 29, 2026 | Kredo Russo Sharon | SVP, Research & Discovery | Grant(A) | 18K | — | $0 |
| Jul 29, 2026 | Kredo Russo Sharon | SVP, Research & Discovery | Grant(A) | 24K | — | $0 |
| Jul 29, 2026 | Livnat Savitzky Kinneret | Director | Grant(A) | 8K | — | $0 |
| Jul 29, 2026 | Livnat Savitzky Kinneret | Director | Grant(A) | 10K | — | $0 |
| Jul 29, 2026 | Hukkelhoven Mathias | Director | Grant(A) | 8K | — | $0 |
| Jul 29, 2026 | Hukkelhoven Mathias | Director | Grant(A) | 10K | — | $0 |
| Jul 29, 2026 | Halevy Gilead | Director | Grant(A) | 8K | — | $0 |
| Jul 29, 2026 | Halevy Gilead | Director | Grant(A) | 10K | — | $0 |
| Jul 29, 2026 | Zweifach Sanford S | Director | Grant(A) | 8K | — | $0 |
| Jul 29, 2026 | Zweifach Sanford S | Director | Grant(A) | 10K | — | $0 |
| Jul 29, 2026 | Mahler Michelle | Chief Medical Officer | Grant(A) | 14K | — | $0 |
| Jul 29, 2026 | Mahler Michelle | Chief Medical Officer | Grant(A) | 18K | — | $0 |
| Jul 29, 2026 | Levine Zurit | SVP, Business Development | Grant(A) | 18K | — | $0 |
| Jul 29, 2026 | Levine Zurit | SVP, Business Development | Grant(A) | 24K | — | $0 |
| Jul 29, 2026 | Silberman David | Chief Financial Officer | Grant(A) | 20K | — | $0 |
| Jul 29, 2026 | Silberman David | Chief Financial Officer | Grant(A) | 26K | — | $0 |
| Jul 29, 2026 | Ophir Eran | President and CEO, Director | Grant(A) | 200K | — | $0 |
| Jul 9, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 2K | $0.83 | $2K |
| Jul 9, 2026 | Levine Zurit | SVP, Business Development | Sell(S) | 2K | $2.50 | $5K |
| Jul 9, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 2K | — | $0 |
| Apr 24, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 2K | $1.15 | $2K |
| Apr 24, 2026 | Levine Zurit | SVP, Business Development | Sell(S) | 2K | $3.20 | $6K |
| Apr 24, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 2K | — | $0 |
| Apr 24, 2026 | Ophir Eran | President and CEO, Director | Option exercise(M) | 5K | $0.83 | $4K |
| Apr 24, 2026 | Ophir Eran | President and CEO, Director | Sell(S) | 5K | $3.20 | $16K |
| Apr 24, 2026 | Ophir Eran | President and CEO, Director | Option exercise(M) | 5K | — | $0 |
| Apr 14, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 2K | $1.15 | $2K |
| Apr 14, 2026 | Levine Zurit | SVP, Business Development | Sell(S) | 2K | $2.80 | $6K |
| Apr 14, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 2K | — | $0 |
| Apr 14, 2026 | Ophir Eran | President and CEO, Director | Option exercise(M) | 5K | $0.83 | $4K |
| Apr 14, 2026 | Ophir Eran | President and CEO, Director | Sell(S) | 5K | $2.90 | $15K |
| Apr 14, 2026 | Ophir Eran | President and CEO, Director | Option exercise(M) | 5K | — | $0 |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 1K | $0.83 | $933 |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 2K | $1.15 | $2K |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | Sell(S) | 3K | $2.56 | $8K |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 1K | — | $0 |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 2K | — | $0 |
| Apr 8, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 4K | $0.83 | $4K |
| Apr 8, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 1K | $1.15 | $1K |
| Apr 8, 2026 | Levine Zurit | SVP, Business Development | Sell(S) | 5K | $2.42 | $13K |
| Apr 8, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 4K | — | $0 |
| Apr 8, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 1K | — | $0 |
| Apr 7, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 3K | $0.83 | $2K |
| Apr 7, 2026 | Levine Zurit | SVP, Business Development | Sell(S) | 3K | $2.30 | $6K |
| Apr 7, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 3K | — | $0 |
| Apr 1, 2026 | Ophir Eran | President and CEO, Director | Option exercise(M) | 6K | $0.83 | $5K |
| Apr 1, 2026 | Ophir Eran | President and CEO, Director | Sell(S) | 6K | $2.21 | $12K |
| Apr 1, 2026 | Ophir Eran | President and CEO, Director | Option exercise(M) | 6K | — | $0 |
| Apr 1, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 3K | $0.83 | $2K |
| Apr 1, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 1K | $1.15 | $1K |
| Apr 1, 2026 | Levine Zurit | SVP, Business Development | Sell(S) | 4K | $2.20 | $8K |
| Apr 1, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 3K | — | $0 |
| Apr 1, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 1K | — | $0 |
| Mar 26, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 12K | $0.83 | $10K |
| Mar 26, 2026 | Levine Zurit | SVP, Business Development | Sell(S) | 12K | $2.04 | $24K |
| Mar 26, 2026 | Levine Zurit | SVP, Business Development | Option exercise(M) | 12K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2008-06-30 → 2026-08-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for CGEN